Regenxbio (RGNX) Interest Expenses (2014 - 2026)
Regenxbio (RGNX) recorded Interest Expenses of $7.79 million in Q2 2026, down 29.1% from $10.99 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Interest Expenses (2014 - 2026) Analysis & Trends
On a TTM basis, Regenxbio's Interest Expenses came in at $44.23 million as of Jun 30, 2026, up 48.4% year-over-year; for FY2025, it came in at $45.01 million, up 255.5% from FY2024.
- Annual Interest Expenses has a five-year compound annual growth rate of 125.6% (FY2020 to FY2025).
- Across earlier years, Interest Expenses came in at $12.66 million in FY2024 (+84.5%), $6.86 million in FY2023 (-70.5%), $23.25 million in FY2022 (-11.5%) and $26.28 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Interest Expenses since Q3 2024.
- On a year-over-year basis, Interest Expenses rose in three of the last five quarters, with growth averaging 175.4%.
- Peak year-over-year performance for Interest Expenses in the last five years was growth of 590.9% in Q4 2024, against a decline of 83.7% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | 7.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.79 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Sep 30, 2025 | 13.17 Mn |
| Jun 30, 2025 | 10.99 Mn |
| Mar 31, 2025 | 8.57 Mn |
| Dec 31, 2024 | 9.42 Mn |
| Sep 30, 2024 | 820,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Jun 30, 2022 | 6.86 Mn |
| Mar 31, 2022 | 6.13 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Sep 30, 2021 | 6.71 Mn |
| Jun 30, 2021 | 6.37 Mn |
API Access
Regenxbio Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();